Why You Should Still Buy Seres Therapeutics, Inc. (NASDAQ:MCRB) Stock Today

Seres Therapeutics, Inc. (NASDAQ:MCRB) shares surged 9.15% during trading on Thursday, going up from its prior closing price of $12.46 to $13.60 , and has now gained 6 consecutive sessions. It is uncommon for a stock to keep rising for so many consecutive days so a temporary pullback is likely.. The stock price went upward in 8 of the last 10 days and has generated 23.3% during the last two weeks. The upbeat movement of both volume and price during the recent session is interpreted as a good sign, and, overall 342 833 more shares exchanged hands compared with prior day. In total, 622 633 shares was the trading volume and the dollar amount of trading equals $8.47 million.

Inside MCRB’s Recent Trend

Seres Therapeutics, Inc. (MCRB) has broken the wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $12.76, a point that may provide a 2nd chance needed to hit a runner. The next trend top is most likely to be exhibited at $15.05 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.

Seres Therapeutics, Inc. Technical Signals

MCRB has witnessed its long term and short term MA triggering a buy signal. Many traders watch for short-term averages to cross above long-term averages to signal the beginning of a uptrend. Upon corrections, the price will meet support from the averages between $11.87 and $10.99. A break down through these support points will trigger sell signals. Its pivot point low generated buy signal on Monday July 10, 2017, which calls for additional surge until the stock forms a new pivot point high. There was increase in both volume and price. This is usually interpreted as a good sign as traders widely believe rising stock should see increasing volume.

Seres Therapeutics, Inc. (NASDAQ:MCRB) Support And Resistance Levels

In case of pullback, the next support the price will capture from accumulated volume will not be far away from current price at $11.68 and $11.21. It seems to be blessed by the accumulated volume as it meets no resistance above current level and favorable trading conditions will help the stock to show strong performance in the coming days.

It is important to note, however, that the stock needs to make its way through natural risk while testing a key support level. Once this support is broken, another support level will be to be established at a lower level. Turning back to this stock, Seres Therapeutics approaches the first support point just current price at $11.68. In case of a break, the next support we will see from accumulated volume is going to be at $11.21 and $10.49.

Seres Therapeutics, Inc. (MCRB) Risk Assessment

A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $1.79 between high and low, or 14.32%. The average volatility for the past week stood at 7.11%.

The stock is extremely overbought on RSI14 (71). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the Seres Therapeutics has been rising for 6 straight session, the volatility is more likely to increase in the next couple of days. We don’t expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.


Previous ArticleNext Article

Related Post

Reviewing the Insider Trends for Vale S.A. (VALE) Recent insider trends for Vale S.A. (NYSE:VALE) have caught the attention of investors. Insider activity is often a strong indicator of future perform...
Critical Comparison: Jones Energy, Inc. (JONE) vs.... Jones Energy, Inc. (NYSE:JONE) shares are down more than -42.73% this year and recently decreased -9.69% or -$0.07 to settle at $0.63. Camber Energy, ...
Pulmatrix, Inc. (PULM) Key Indicators And Emerging... Pulmatrix, Inc. (NASDAQ:PULM) gained 4.78% in yesterday’s session, going up from its prior closing price of $2.09 to $2.19, and has now recorded rally...
Kimco Realty Corporation (KIM) vs. Abercrombie �... Kimco Realty Corporation (NYSE:KIM) shares are down more than -18.57% this year and recently increased 1.86% or $0.27 to settle at $14.78. Abercrombie...
What do Insider Trends Have to Say About Atossa Ge... Recent insider trends for Atossa Genetics Inc. (NASDAQ:ATOS) have caught the attention of investors. Patters in insider activity can help analysts for...